Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study genetic testing and the effectiveness of irinotecan in treating
patients who have solid tumors and lymphoma. Drugs used in chemotherapy use different ways to
stop cancer cells from dividing so they stop growing or die. Genetic testing for a specific
enzyme may help doctors determine whether side effects from or response to chemotherapy are
related to a person's genetic makeup